NewLimit

South San Francisco, CA · Founded 2021 · Privately Held (backing)

Developer of precision medicines designed for epigenetic reprogramming to restore youthful function in aging cells. NewLimit is based in South San Francisco, CA and was founded in 2021. It was valued at $1.6 billion at its early-stage round in Oct 2025, the last priced event on record. It has raised $247 million across 2 recorded rounds; the latest was a $130 million later-stage round in May 2025.

PMV mark · valuation
$1.6B
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$247.3M
Last round
Later Stage VC
May 2025
What is NewLimit worth?
$1.6BPrivateMarketView mark · Oct 2026

Valued at $1.6B at its early-stage round, Oct 2025. Nothing has traded since.

Free account
More of NewLimit with a free account
  • ·The complete investor list: 24 names
  • ·Watch NewLimit: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

NewLimit funding history

2 rounds
DateRoundRaisedPost-money
May 2025Later Stage VC$129.8M▮
May 2023Later Stage VC$72.2M▮
Unlock post-money valuations

Membership and data by Private Market View

NewLimit valuation

NewLimit was valued at $1.6 billion at its early-stage round in Oct 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has NewLimit raised?

NewLimit has raised $247 million across 2 recorded rounds since 2023. The largest was a $72.2 million later-stage round in May 2023; the most recent was a $130 million later-stage round in May 2025.

NewLimit has filed 3 Form Ds with the SEC since 2023, most recently in May 2025 ($130 million sold to 38 investors).

How NewLimit's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For NewLimit, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about NewLimit

What is NewLimit worth?
NewLimit is valued at $1.6B as of Oct 2026. Valued at $1.6B at its early-stage round, Oct 2025. Nothing has traded since.
How much has NewLimit raised?
NewLimit has raised $247.3M in total funding across 2 recorded rounds.
When did NewLimit last raise?
NewLimit last raised in May 2025 (Later Stage VC), raising $129.8M.